People icon

TECVAYLI® is a prescription medicine to treat adults with multiple myeloma who:

  • have already received at least 4 treatment regimens, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody to treat their multiple myeloma, and
  • their cancer has come back or did not respond to prior treatment

TECVAYLI® was approved based on patient responses. There are ongoing studies to confirm the clinical benefit of TECVAYLI®.

It is not known if TECVAYLI® is safe and effective in children.

See results from the TECVAYLI® clinical trial

TECVAYLI® is the first treatment of its kind for multiple myeloma—it’s called a , and it works by binding to both multiple myeloma cells as well as to help your recognize the multiple myeloma cells and destroy them.

Cartoon t-cell and multiple myeloma cell

Learn more about how TECVAYLI® works

TECVAYLI® was studied in 110 heavily pretreated people:

62%

62%Responded to
TECVAYLI®

All patients had previously received a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody:

  • At least half of the patients received at least 5 prior regimens
  • 78% of patients had 4 prior treatment regimens

Talk your doctor for more information about response.

Learn more about response with TECVAYLI®

RESPONSE WITH TECVAYLI® 62% of people in the clinical trial who took TECVAYLI® responded.

SUBCUTANEOUS INJECTION TECVAYLI® is given by a doctor or nurse as a subcutaneous injection under the skin, usually in your stomach area (abdomen), your thigh, or another area of your body.

WORKS DIFFERENTLY TECVAYLI® works by binding to both multiple myeloma cells as well as T-cells to help your immune system recognize the multiple myeloma cells and destroy them.

Learn more about TECVAYLI®

If your multiple myeloma is refractory or relapsed, ask your healthcare provider if TECVAYLI® is right for you.

Steps to talking to your doctor about TECVAYLI® (teclistamab-cqyv)

Learn more about TECVAYLI®

Man in blue t-shirt with arms folded staring to his left
Play button icon

MEET MIKE

I have the greatest support staff—my amazing wife, my children, my parents, my family.

home-gradient-short

Mike is a real patient who’s been living with multiple myeloma for over 8 years. Listen as he and his wife discuss his journey from diagnosis through relapse, as well as their relationship as both husband and wife and patient and care partner.

Mike received TECVAYLI®

Recycle icon

There are still options for you after relapse

When you have multiple myeloma, the medicines that were working before can stop working, and you can experience relapse. When you try a medicine but don’t get a , this means your multiple myeloma is refractory to that medicine.

There are still ways to fight , including trying a different medicine from the kinds you have already tried.

If your multiple myeloma is refractory or relapsed, ask your healthcare provider if TECVAYLI® is right for youTECVAYLI® is for adults with multiple myeloma whose cancer has come back or did not respond to treatment after having received at least 4 prior , including:

  • Green bullet pointa proteasome inhibitor
  • Green bullet pointan immunomodulatory agent
  • Green bullet pointan anti-CD38 monoclonal antibody

TECVAYLI® was approved based on patient responses. There are ongoing studies to confirm the clinical benefit of TECVAYLI®. It is not known if TECVAYLI® is safe and effective in children.

Man in blue sweatshirt eating an orangeMan in blue sweatshirt eating an orange

If you’re going through another relapse, it may be time to talk to your doctor about making a change

There are medicines for relapsed or refractory multiple myeloma that may be able to help manage your disease. Talk to your doctor to see if TECVAYLI® is right for you.

 

Once you and your doctor have decided that TECVAYLI® is right for you, sign up for TECVAYLI withMe

TecvayliWithMe icon

TECVAYLI withMe: Personalized 1-on-1 Support

You have access to free, dedicated support. Your Care Navigator is here to help guide you to support solutions throughout your treatment journey, so you feel informed and empowered.

Starting a new treatment can be overwhelming and you may still have questions. We are here to help.

  • Patient1on1 icon

    Free 1-on-1 Dedicated Care Navigator Support

  • PatientIconCostSupport icon

    Cost Support Options Regardless of Your Insurance Type

  • PatientAdditionalResources icon

    Additional Resources and Community Connections

OR

The support and resources provided by TECVAYLI withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.